ArticleJournal of clinical medicine2023

Delta Radiomics Model Predicts Lesion-Level Responses to Tyrosine Kinase Inhibitors in Patients with Advanced Renal Cell Carcinoma: A Preliminary Result.

Yuntian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.